In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

AGORACOM News Flash

2 Big Announcements On AGORACOM Blog Today:

1]  Billionaire Investor, George Soros, Takes 5.19% Stake (11.7 million shares) In AGORACOM Client. Which Company? Full Story Here.

2] AGORACOM Acquires www.Grandich.com and Appoints Peter Grandich As Chief Commentator. Full Story Here.  New Grandich Blog Here.

Regards,
George

 

AlphaRx > Message
Generic_profile

Re: End of phase II milestone payment

Posted by: Never_Post on March 22, 2008 07:41PM

In response to: Re: End of phase II milesto... by mavenwood

Mavenwood,

OK, as long as you are being honest, I too have bought on probably two occasions to support the price. Though I hold probably a little more than 1/3 of your shares, I plan to get back to a owning a round number of shares hence the buying - so a fairly large investment.

Regarding the Bid and Ask, the market is all emotion and if the major indices are down then investors are inclined to sell and go to cash. I am quit surprised that ALRX has not sold down more, it seems when the price drops that investors are ready to buy, and after all it is a drug company.

Just curious, do you talk to Michael Lee on a regular basis? I have not been able to get in contact with him for a long time, and the IR firm never bothered to return my call though I am sure I would have asked questions that they would not have answered.

IMO - I believe that after the TSX listing it will be a toss up between phase III approval to start testing of Indaflex or results from the major phamaceutical company.

Best Regards

Post a Reply

Please login to reply to this message.

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote